About Us
At TeleDaaS™, our team of expert physicians and specialists employs cutting-edge technology to deliver accurate and effective dosimetry services. Pioneering Dosimetry-as-a-Service with a unique approach, we remain at the forefront of evidence-based medicine.
Personalizing Theranostics
At TeleDaaS, we prioritize every dose, striving to advance precision medicine and expedite cancer care. Our mission is to redefine dosimetry through unparalleled solutions tailored for clinical trials. Committed to innovation and excellence, we aim to ensure precise care for each patient.
Dosimetry Matters Because Dose Matters
Unlocking Success in Clinical Trials with Personalized Dosimetry
Everyone's cancer is unique requiring a personalized dose and treatment. Personalized dosimetry as a solution proven to improve outcomes in clinical trials with Boston Scientific's Y90 Therasphere™. Personalization is widely accepted as the preferred process, yet it is not universally adopted. We are here to change that.
Our Team & Advisory Network
Shelby Schweitzer
VP Service Delivery
Dr. Mark Crockett
Chief Medical Officer
Dr. Julien Willaime
VP Science & Research
Dr. Shamar Young
Interventional Oncologist
(Advisor)
Dr. Djamal Boukerroui
Senior Research Scientist
Dr. John Sage
Senior Research Scientist
Dr. Daniel Balfour
Research Scientist
Dr. Padraig Looney
Research Scientist
Liza Collins
Operations Specialist
Samantha Heasty
Certified Nuclear Medicine Technologist
Clinical Expertise
At TeleDaaS, our clinical team is comprised of a passionate and highly qualified group of licensed physicians and technologists. They are at the forefront of the dosimetry industry, consistently delivering personalized dosimetry treatment plans day in and day out.
Scientific Expertise
Our advisors have built a strong reputation as scientific leaders in the industry, with a dedicated research team of PhD level scientists combining more than 90 years of experience in medical imaging, medical physics, and clinical translation. Our commitment to rigorous scientific standards and practices, earns us the trust of sponsors and partners alike.
